167 related articles for article (PubMed ID: 128637)
21. Mutagenic activity of 4-nitroquinoline 1-oxide and 4-hydroxyaminoquinoline 1-oxide in Neurospora crassa.
Matter BE; Ong T; De Serres FJ
Gan; 1972 Apr; 63(2):265-7. PubMed ID: 4262705
[No Abstract] [Full Text] [Related]
22. Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs.
Pica-Mattoccia L; Cioli D
J Parasitol; 1986 Aug; 72(4):531-9. PubMed ID: 3783347
[TBL] [Abstract][Full Text] [Related]
23. Mutagenic potency and specificity of procarbazine in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
Brockman HE; de Serres FJ
Mutat Res; 1991 Jan; 246(1):193-204. PubMed ID: 1824718
[TBL] [Abstract][Full Text] [Related]
24. Anticholinergic properties of the antischistosomal drug hycanthone.
Hillman GR; Senft AW
Am J Trop Med Hyg; 1975 Sep; 24(5):827-34. PubMed ID: 1190369
[TBL] [Abstract][Full Text] [Related]
25. Effect of N2 on the mutagenic and lethal activities of ICR-170 in Neurospora crassa.
Whong WZ
Mutat Res; 1979 May; 60(3):301-12. PubMed ID: 90338
[TBL] [Abstract][Full Text] [Related]
26. Mutagenicity of chemical carcinogens in Neurospora crassa.
Ong TM; De Serres FJ
Cancer Res; 1972 Sep; 32(9):1890-3. PubMed ID: 4264527
[No Abstract] [Full Text] [Related]
27. Ageing of Neurospora crassa. VIII. Lethality and mutagenicity of ferrous ions, ascorbic acid, and malondialdehyde.
Munkres KD
Mech Ageing Dev; 1979 May; 10(3-4):249-60. PubMed ID: 156825
[TBL] [Abstract][Full Text] [Related]
28. Early steps in mutagenesis by hycanthone.
Bases R; Mendez F; Elequin F; Liebeskind D; Kozin A; Neubort S
Cancer Res; 1978 Mar; 38(3):781-6. PubMed ID: 626982
[TBL] [Abstract][Full Text] [Related]
29. Experimental chemoprophylaxis against schistosomiasis. II. Stage I comparison of lucanthone, hycanthone, niridazole and oxamniquine (UK 4271).
Jewsbury JM
Ann Trop Med Parasitol; 1973 Dec; 67(4):431-8. PubMed ID: 4787715
[No Abstract] [Full Text] [Related]
30. Influence of N2 or O2 on two alkylating agents in Neurospora crassa.
Seyfried TN
Mutat Res; 1975 May; 28(2):155-62. PubMed ID: 49017
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the genetic activity of 5-nitroimidazole derivatives in Escherichia coli, Neurospora crassa, Saccharomyces cerevisiae and Drosophila melanogaster.
Mohn GR; Ong TM; Callen DF; Kramers PG; Aaron CS
J Environ Pathol Toxicol; 1979; 2(3):657-70. PubMed ID: 154545
[TBL] [Abstract][Full Text] [Related]
32. Effect of pH on the mutagenic and killing potencies of ICR-170 in ad-3 tests of Neurospora crassa.
Whong WZ; Ong T; Brockman HE
Mutat Res; 1985; 142(1-2):19-22. PubMed ID: 2579330
[No Abstract] [Full Text] [Related]
33. Mutagenic action of hycanthone and IA-4 on yeast.
Meadows MG; Quah SK; von Borstel RC
J Pharmacol Exp Ther; 1973 Nov; 187(2):444-50. PubMed ID: 4356017
[No Abstract] [Full Text] [Related]
34. Effect of the uvs-2 allele of Neurospora crassa on the mutagenic potency of two N-hydroxylaminopurines and 2-aminopurine in the ad-3 forward-mutation test.
Brockman HE; de Serres FJ; Hung CY; Ong T
Mutat Res; 1989 Jul; 218(1):1-11. PubMed ID: 2526296
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the cytotoxic and mutagenic effects of selected mutagens on excision repair-sufficient and -deficient AD-3 mutants of Neurospora crassa.
Ong T; Converse JO
Mutat Res; 1983 Oct; 124(1):61-7. PubMed ID: 6226873
[TBL] [Abstract][Full Text] [Related]
36. Genetic characterization of adenine-3 mutants induced by 4-nitroquinoline 1-oxide and 4-hydroxyaminoquinoline 1-oxide in Neurospora crassa.
Ong T; Matter BE; de Serres FJ
Cancer Res; 1975 Feb; 35(2):291-5. PubMed ID: 122814
[TBL] [Abstract][Full Text] [Related]
37. The testing of 4CMB, 4HMB and BC for mutagenicity in a new Neurospora crassa heterokaryon.
Luker MA
Mutat Res; 1982; 100(1-4):123-6. PubMed ID: 6460177
[TBL] [Abstract][Full Text] [Related]
38. Mutagenicity of neocarzinostatin in Neurospora crassa.
DeGraff WG
Mutat Res; 1984 Sep; 128(2):127-35. PubMed ID: 6236365
[TBL] [Abstract][Full Text] [Related]
39. The use of Neurospora in the evaluation of the mutagenic activity of environmental chemicals.
de Serres FJ
Environ Mutagen; 1983; 5(3):341-51. PubMed ID: 6221926
[TBL] [Abstract][Full Text] [Related]
40. Forward-mutation tests on the antitumor agent ICR-170 in Neurospora crassa demonstrate that it induces gene/point mutations in the ad-3 region and an exceptionally high frequency of multiple-locus ad-3 mutations with closely linked sites of recessive lethal damage.
de Serres FJ; Malling HV
Mutat Res; 1994 Oct; 310(1):15-36. PubMed ID: 7523879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
